Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Synchrodyn

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1988
1988
The objective of the present study was to determine the circadian effects of melatonin and two different ACTH preparations: a… Expand
Review
1987
Review
1987
An increasing number of ACTH-related peptides have been isolated and/or chemically synthesized. In addition to the multiplicity… Expand
1985
1985
It is now established that peptide hormones are among the most versatile substances involved in intercellular communications. By… Expand
Review
1984
Review
1984
SummaryA number of immunological functions has been found to be endowed with biological rhythmicity. Variations of peripheral… Expand
1984
1984
SummaryThe effect of administration of a synthetic ACTH analogue (ACTH 1–17, Synchrodyn®) in the chemotherapy of advanced-phase… Expand
1984
1984
SummarySince November 1981, 90 cancer patients treated with cytotoxic chemotherapy (CMF, FAC, FAM) have been studied to evaluate… Expand
1984
1984
SummaryWe have studied the effect of Synchrodyn® 1–17 (100 μg/day/15 days, intramuscularly) on 12 patients with intrinsic asthma… Expand
1984
1984
SummaryIn this study we have compared the effects of the ACTH 1–17 analogue, alsactide (Synchrodyn® 1–17,) and of the ACTH 1–24… Expand
1981
1981
The effect of placebo and ACTH-1-17 (Synchrodyn, Hoechst) upon urinary free cortisol was examined at 5 different circadian stages… Expand
1980
1980
A synthetic short chain ACTH, ACTH-1-17 (HOE 433 = Synchrodyn 1-17), beta-ala1, lys17 corticotropin (1-17)heptadecapeptide-4-N… Expand